CN Stock MarketDetailed Quotes

Hubei Biocause Heilen Pharmaceutical (301211)

Watchlist
  • 11.08
  • +0.12+1.09%
Post Market May 19 15:00 CST
4.63BMarket Cap136.79P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Heilen Pharmaceutical (301211) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
非甾体抗炎类308.41M68.04%
Cardiovascular class67.49M14.89%
Other51.25M11.31%
Antitumor class26.15M5.77%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Raw material medicine338.34M74.64%
Preparation107.46M23.71%
Other7.5M1.66%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory250.64M55.29%
Overseas202.66M44.71%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.54%
Sample Name
Sample Code
 +4.33%
Sample Name
Sample Code
 +0.27%
4
SINOPEC CORP
00386
-0.44%
5
SHANGHAI PECHEM
00338
-0.81%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +42.01%
Sample Name
Sample Code
 +32.82%
Sample Name
Sample Code
 +26.86%
4
Emdoor Information
001314
+25.83%
5
Digital China Group
000034
+20.88%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -